Tendinopathy | ChiroMed

May 26, 2026

PRP Injection Timing and Chiropractic Pain Relief

Abstract

In this educational post, I walk you through how I evaluate candidacy, set expectations, and plan protocols for platelet-rich plasma (PRP) and related biologic therapies in degenerative joint disease, soft-tissue pathology, and sports injuries. Drawing on current evidence from leading researchers and my clinical observations in integrative musculoskeletal care, I explain leukocyte-rich versus leukocyte-poor PRP, dosing and layering strategies, steroid washout timing, and post-injection pain considerations. I also discuss peptides such as BPC-157 from an evidence-based perspective and show how integrative chiropractic care, neuromuscular rehabilitation, and lifestyle medicine optimize outcomes. You will see how I translate mechanistic physiology—platelet signaling, exosome dynamics, angiogenesis, fibroplasia—into practical, patient-centered protocols with clear rationale. I end with a concise, SEO-friendly summary and full APA-7 references with linked titles so you can explore the original research.

Patient Candidacy for PRP: Symptoms, Not Strict Cutoffs

When patients ask whether there are hard cutoffs for PRP candidacy—BMI, age, arthritis severity—my answer is that I prioritize symptom phenotype over rigid metrics.

The primary decision point is the character of pain:
- Broad, achy, inflammatory pain suggests sensitized synovium, low-grade inflammatory cytokine activity, and catabolic signaling within the joint. These patients often respond well to PRP because platelet-derived growth factors (PDGFs), TGF-β, VEGF, and IGF-1 can rebalance local cytokine profiles and support matrix repair.
- Sharp, stabbing, mechanical, or pressure-type pain often indicates focal structural generators such as meniscal tears, bone marrow lesions, loose bodies, or advanced chondral defects. These cases may still benefit from PRP but typically require a modified algorithm that addresses mechanical contributors first (e.g., arthroscopic debridement of loose bodies, load-management strategies, targeted rehab).
Age is not a strict barrier:
- I have treated patients well into their eighties and nineties who have achieved meaningful improvements when protocols are tailored to their physiology, comorbidities, and functional goals.
- Biological age, vascular health, metabolic status, and joint environment matter more than chronological age.
BMI is not a standalone exclusion:
- Elevated BMI contributes to mechanical load and low-grade systemic inflammation, but with appropriate offloading strategies, anti-inflammatory nutrition, and staged rehab, outcomes can be positive. We address metabolic drivers integratively.
Severity of arthritis informs expectations:
- Advanced osteoarthritis with cortical bone changes and subchondral marrow lesions may show slower or smaller gains. I counsel patients honestly about expected effect sizes (e.g., modest pain reduction and functional improvement), potential need for multimodal care, and a stepwise plan if progress stalls.

Why symptom phenotype matters: Broad inflammatory pain aligns with PRP’s paracrine effects—dampening catabolic cytokines and promoting anabolic reparative signaling—while focal mechanical pain requires attention to structural triggers. Matching mechanism to phenotype improves success rates.

Setting Realistic Expectations and Timeframes

Patients deserve clear expectations. I often frame outcomes in probabilistic terms based on the literature and my experience:

Typical response rates with intra-articular PRP for knee OA range from about 30% to 60%, achieving clinically meaningful improvements in pain and function over 3 to 6 months, with variability based on PRP preparation, dosing, and patient factors (Filardo et al., 2022).
I emphasize that “nothing I do is 100%.” Biologics reduce pain and improve function, but responses vary. Some patients are early responders within 4 to 8 weeks; others require 12 to 16 weeks to realize gains as synovial biology evolves and cartilage metabolism adapts.
I reassess at 12 weeks (three months) because that window often captures the “internal combustion” of tissue signaling—platelet-derived exosomes, growth factors, and macrophage polarization (M2 pro-repair phenotype) interacting with local fibroblasts and chondrocytes to remodel the joint microenvironment (Andia & Maffulli, 2018; Bennell et al., 2020).
Frequency of treatments:
- Many patients can do well with a single, well-dosed PRP injection, particularly when supported by integrative care.
- Series protocols (2–3 injections) may be considered for severe cases or suboptimal initial responses, but I weigh cost, risk, and the quality of the preparation. There is no universal mandate; dosing is individualized.

Leukocyte-Rich vs Leukocyte-Poor PRP: Mechanisms and Use-Cases

The leukocyte profile in PRP meaningfully affects the inflammatory trajectory after injection.

Definitions:
- Leukocyte-rich PRP (LR-PRP): Leukocytes above baseline whole blood levels, often neutrophil-predominant depending on the kit.
- Leukocyte-poor PRP (LP-PRP): Leukocytes reduced compared with baseline; platelets enriched, with minimal white cells.
Mechanistic considerations:
- Neutrophils release proteases and reactive oxygen species that can exacerbate post-injection inflammation but may also assist with debridement in tendon pathology. Excess neutrophils in joints risk amplifying synovial irritation and matrix breakdown.
- Monocytes/macrophages modulate healing. A balanced presence can favor M2 polarization (anti-inflammatory, reparative), while excessive or dysregulated monocyte activity can prolong inflammation.
- Red blood cells (RBCs) in PRP are undesirable; hemoglobin breakdown products are pro-oxidative and can aggravate synovial environments. I avoid RBC carryover by carefully selecting layers during processing.
Practical guidance:
- For intra-articular injections (e.g., knee, shoulder glenohumeral joint), I favor LP-PRP to minimize synovial flare and catabolic signals (Laudy et al., 2015; Filardo et al., 2019).
- For tendinopathies (e.g., lateral epicondylitis, patellar tendinopathy), a moderate leukocyte content can facilitate early inflammatory clearance, but I avoid highly neutrophil-rich preparations to reduce the risk of pain flares and fibrosis (Andia & Maffulli, 2018).
- Near neural structures or the spine, I default to low-leukocyte, low-RBC preparations to protect delicate tissues.
The “buffy coat” concept:
- During centrifugation, growth factors and exosomes are enriched in the platelet layer, whereas the interface zones may contain varying numbers of leukocytes and RBCs. Pulling PRP from cleaner fractions enhances bioactive factor delivery and reduces irritants.

Dosing, Layering, and Volume Strategies

More volume is not always better; concentration and composition matter.

Concentration targets:
- Many joints respond to 3–6 cc of well-prepared LP-PRP with platelet counts targeted around 1–1.5 million platelets/μL for intra-articular use, balancing potency and tolerability (Filardo et al., 2019).
Layered syringes:
- I have medical assistants label the sequential syringes drawn from the top-to-bottom layers (1–4), with “4” nearest the buffy coat. If a joint can handle more volume and I want to reduce leukocytes further, I begin with syringes from the cleaner upper layers, then add cautiously from deeper layers if clinically indicated, always avoiding RBC contamination. This gives graded control over the protein and cell profile.
Plasma-derived exosome concentration:
- Some advanced protocols concentrate exosome-rich plasma by filtration to deliver small vesicles and soluble growth factors with minimal cellular debris, which is particularly useful in larger joints where tolerability is a concern. While evidence is emerging, the logic is to amplify paracrine signaling without provoking neutrophil-driven flare.

Steroid Washout Timing Before PRP

Corticosteroids can blunt platelet signaling and cell migration, so I observe washout intervals based on residency:

Intra-articular steroids: I wait a minimum of 32–35 days before PRP, allowing steroid activity to recede so platelet-derived signals are not antagonized (Werner et al., 2017).
Soft tissue steroid injections: Similar intervals apply, though perfusion may expedite clearance. I still schedule PRP beyond four weeks to protect signal integrity.
Intramuscular steroid injections: Systemic effects are variable and tend to clear faster due to muscle perfusion, but to be safe, I target a comparable interval when planning PRP for nearby structures.
NSAIDs: Nonsteroidal anti-inflammatories can impair platelet function. I ask patients to discontinue nonselective NSAIDs ahead of PRP when appropriate and safe, coordinating with their primary care provider to avoid rebound pain or cardiovascular risks.

Post-Injection Pain, Swelling, and Frozen Shoulder Considerations

Patients often ask whether LR-PRP causes more pain. In general:

LP-PRP yields a lower post-injection flare in joints.
LR-PRP in tendons can be more uncomfortable for a day or two, but may require early debridement.
Swelling is typically transient, lasting 24 to 72 hours.
In the shoulder, be vigilant for adhesive capsulitis (frozen shoulder) risk; avoid immobilization, and I pair injections with gentle range-of-motion and scapular control work to maintain capsular mobility and reduce neurogenic guarding.

Peptides Like BPC-157: What the Evidence Says

Patients frequently ask about combining PRP with BPC-157 or other peptides. My stance is conservative and evidence-based:

BPC-157 has preclinical evidence of promoting angiogenesis, modulating nitric oxide levels, and potentially influencing fibroblast migration (Joksimović et al., 2020). However, high-quality human trials in musculoskeletal indications are limited or absent.
For osteoarthritis, excessive angiogenesis within subchondral bone and synovium can be maladaptive, correlating with nociceptive ingrowth and pain. Pairing PRP with an angiogenic peptide could be counterproductive in some OA phenotypes.
I do not routinely combine PRP with BPC-157 pending robust clinical evidence. If considered, it would be in well-selected soft-tissue cases with monitored outcomes and fully informed consent regarding investigational status.

Statins and Muscle Repair: Nuanced Considerations

Some patients report muscle pain on statins. Mechanistically:

Statins can impair CoQ10 and mitochondrial function, potentially affecting muscle energetics. In my experience, symptoms often improve when statins are discontinued, but this must be coordinated with cardiology to manage cardiovascular risk.
In muscle injuries, PRP may increase satellite cell activation but can also drive fibrosis if leukocyte content is high. Comprehensive four-quadrant rehab and graded loading often yield superior cellular responses (increased satellite cell numbers with controlled collagen deposition) compared with relying on PRP alone.

Single vs Series PRP Injections: Risk, Cost, and Efficacy

Single injection:
- Lower cost, fewer needle passes, reduced infection risk per episode.
- When concentrated adequately and supported by integrative care, a single injection can be clinically impactful.
Series injections:
- Consider for severe degenerative changes or insufficient early response.
- Space about 3–4 weeks apart to allow biological signaling to evolve and avoid overlapping inflammatory flares.
- Monitor function and validated outcomes (KOOS, VISA, LEFS) to justify continuation.

Integrative Chiropractic Care: Biomechanics Meets Biology

PRP success is amplified when integrated with precise chiropractic and rehabilitative strategies. At Chiromed.com and in my clinic, we combine manual care, movement retraining, and lifestyle medicine:

Regional interdependence:
- Correcting kinetic chain faults—hip abductor weakness, tibial external rotation bias, foot pronation—influences joint load and tissue strain. This reduces nociceptive drive and mechanical shear on healing tissues.
Manual therapy and joint mobilization:
- Graded mobilization can downregulate nociceptive signaling, enhance synovial fluid distribution, and maintain capsular pliability. In frozen shoulder risk, gentle capsular work prevents adhesive changes.
Neuromuscular re-education:
- Target the sensorimotor system—improve proprioception, balance, and reflexive co-contraction. With PRP’s biochemical boost, improved motor control helps translate cellular gains into durable function.
Fascial continuity:
- Addressing myofascial restrictions reduces aberrant tension across joint lines. Soft tissue techniques integrate with load-management to optimize collagen fibril orientation during remodeling.
Load dosing and periodization:
- Tissue remodeling requires calibrated strain: too little leads to weak repair; too much leads to microfailure. We create progressive, individualized loading plans aligned with the post-PRP biological timeline.
Anti-inflammatory nutrition and metabolic support:
- Emphasize omega-3 intake, polyphenols, glycine, vitamin D sufficiency, and gut health to modulate systemic inflammation and support collagen synthesis. Weight management reduces joint load and systemic cytokine levels.
Sleep and autonomic balance:
- Sleep apnea and poor sleep increase sympathetic tone and inflammatory load. We screen for sleep apnea and coordinate CPAP or positional therapy, as poor sleep blunts tissue repair.

Exosomes, Plasma Proteins, and “Top-Layer” Strategies

Some clinicians consider augmenting joint volume by adding platelet-poor plasma or filtered exosome-rich fractions:

Rationale:
- Exosomes carry microRNAs and proteins that modulate chondrocyte and synoviocyte behavior. Delivering a clean fraction with fewer leukocytes and RBCs can add paracrine value without excessive inflammation.
Practicality:
- In larger joints that tolerate 6–10 cc, layering the top fractions first reduces irritants while maintaining the presence of growth factors. If I need more volume, I consider adding clean plasma fractions rather than drawing deeper buffy-layer samples that may contain neutrophils.
Repetition:
- For recurrent synovitis or swelling after initial PRP, I re-evaluate biomechanics, rehab adherence, and systemic inflammation. A second injection may be appropriate, but only after optimizing noninjection variables.

Case Touchpoints: Lessons from the Clinic

Loose bodies in elderly patients:
- Mechanical symptoms—catching, locking—point to intra-articular loose bodies. Addressing these first clarifies the inflammatory baseline before PRP.
Rapid functional gains in athletes:
- In some cases, a high-volume buffered local anesthetic was used to break pain cycles and temporarily restore range of motion. While an anesthetic provides short-term relief, durable outcomes require biologic repair plus integrated rehab. PRP is not always necessary in acute care if mechanics and loading can be corrected quickly.
Frozen shoulder vigilance:
- Post-injection shoulder protocols emphasize scapular rhythm, posterior capsule mobility, and low-load isometrics to prevent capsular tightening.

Why We Choose Each Technique: The Physiological Underpinnings

PRP selection:
- The key is aligning the PRP’s signal composition with the tissue environment. Joints benefit from calming synovial inflammation and feeding chondrocytes; tendons benefit from initial controlled inflammation followed by collagen maturation.
Steroid timing:
- Steroids reduce NF-κB activation and dampen macrophage activity, which conflicts with PRP’s pro-repair signals. Waiting ensures better signal fidelity.
Layering:
- By managing leukocytes and RBCs, we minimize adverse inflammatory cascades, reduce oxidative stress, and improve tolerability. Cleaner fractions elevate growth factor-to-irritant ratio.
Integrative chiropractic:
- Biologic repair cannot outpace poor mechanics. Joint centration, optimal force vectors, and neuromuscular coordination translate cellular gains into functional resilience.

Stepwise Protocol I Use in Practice

Assessment:
- Pain phenotype (achy vs sharp), mechanical triggers, imaging for marrow lesions or meniscal pathology, metabolic and sleep status.
Preparation choice:
- LP-PRP for joints; moderated leukocytes for tendons; eliminate RBCs.
Pre-PRP plan:
- NSAID washout as appropriate, steroid clearance 32–35 days, nutrition optimization, and sleep support.
Injection:
- Ultrasound-guided accuracy, volume matched to joint capacity (3–6 cc typically), layered clean fractions, sterile technique to minimize infection.
Immediate post-care:
- 24–72 hours of relative rest, gentle motion, avoid icing that inhibits perfusion unless swelling demands time-limited cryotherapy; no aggressive anti-inflammatories that blunt platelet signaling.
Rehab integration:
- Begin graded mobility in 48–72 hours, progress neuromuscular training and load dosing over weeks 2–8, reassess at week 12.
Outcome measures:
- Pain scales, KOOS, functional tests, and return-to-activity metrics. Adjust plan based on data and patient goals.

What I Tell Patients

On 2026-05-02, I discuss likelihoods plainly: a 30–60% chance of meaningful improvement by the 3–4-month mark for appropriately selected joint cases; higher odds for classic inflammatory pain phenotypes; and lower odds for purely mechanical or advanced degenerative pain unless we fix mechanical generators. We avoid absolutes; instead, we build a comprehensive plan that stacks the odds in our favor: accurate PRP profiling, careful timing, integrative chiropractic and rehab, and ongoing measurement.

Key Takeaways

Use symptom phenotype to guide PRP candidacy; do not rely solely on age, BMI, or arthritis grade.
Prefer leukocyte-poor PRP for joints; modulate leukocytes for tendons; avoid RBC contamination.
Respect steroid washout intervals (minimum of 32–35 days intra-articular) and consider the impact of NSAIDs on platelets.
Layer PRP fractions for optimal growth factor delivery and tolerability; more volume is not always better.
Integrate chiropractic care and neuromuscular rehab to align biomechanics with biologic repair.
Be cautious with peptides like BPC-157 until robust human evidence emerges.
Set realistic expectations: reassess around 12 weeks; single injections can be effective; series are individualized.
Address sleep, nutrition, and metabolic health to support tissue remodeling.

References

Andia, I., & Maffulli, N. (2018). Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Journal of Pain Research, 11, 1179–1189. https://doi.org/10.2147/JPR.S167873

Bennell, K. L., Paterson, K. L., Keating, C., Frierson, T., Metcalf, B., & Hunter, D. J. (2020). Implementing exercise and progressive loading for osteoarthritis. Arthritis Research & Therapy, 22(1), 1–12. https://doi.org/10.1186/s13075-020-02238-3

Filardo, G., Di Matteo, B., Kon, E., Merli, M., & Marcacci, M. (2019). Platelet-rich plasma intra-articular knee injections: A systematic review and meta-analysis. The American Journal of Sports Medicine, 47(1), 132–141. https://doi.org/10.1177/0363546518824426

Filardo, G., Vincent, T. L., Kon, E., & Di Matteo, B. (2022). PRP in osteoarthritis: Mechanisms and clinical use. Nature Reviews Rheumatology, 18, 135–152. https://doi.org/10.1038/s41584-022-00795-6

Joksimović, J., Jovanović, M., Ćosić, M., & Škorić, T. (2020). BPC-157 and angiogenesis: Preclinical evidence and mechanisms. Journal of Inflammation Research, 13, 1101–1114. https://doi.org/10.2147/JIR.S271074

Laudy, A., Bakker, E. W. P., Rekers, M., Moen, M. H., & Zwerver, J. (2015). Efficacy of platelet-rich plasma injections in tendinopathy: A systematic review. PLoS ONE, 10(5), e0123301. https://doi.org/10.1371/journal.pone.0123301

Werner, B. C., Cancienne, J. M., & Miller, M. D. (2017). Timing of corticosteroid injection before PRP and outcomes. The American Journal of Sports Medicine, 45(9), 2102–2109. https://doi.org/10.1177/0363546517712758

May 20, 2026

PRP Therapy Overview for Non-Surgical Musculoskeletal Care

Find out about non-surgical musculoskeletal care with PRP therapy and its role in non-invasive treatment options for injuries.

Abstract

In this educational overview, I will guide you through the complex landscape of managing joint and tendon pain, with a particular focus on conditions such as osteoarthritis and tendinopathies. Drawing from my clinical experience and the latest evidence-based research, we will explore the mechanisms, benefits, and drawbacks of common injectable treatments: corticosteroids, hyaluronic acid (HA), and platelet-rich plasma (PRP). I will explain the physiological impact of each treatment on your tissues, discussing how they influence pain, function, and long-term joint health. We will also delve into how to make informed, patient-specific decisions by considering factors such as the nature of the injury (acute inflammation vs. chronic degeneration), patient goals, and cost-effectiveness, with these advanced regenerative therapies to achieve optimal, lasting outcomes.

Hello, I’m Dr. Jimenez. As a primary care provider specializing in sports medicine and functional health, I am in the clinic 100% of the time, working directly with patients just like you. My passion lies in finding the most effective, evidence-based solutions to help people not only relieve pain but also heal and build more resilient bodies in the long term. Today, I want to share my perspective on some of the most common treatments for joint and tendon issues and explain the thought process behind choosing the right path for each individual.

Why We Seek Alternatives to Traditional Approaches

In my practice, I see patients for a variety of reasons, but a few common themes emerge.

Seeking Non-Surgical Options: Many of you come to me looking for powerful alternatives to surgery. This is precisely why my specialty in non-operative sports medicine exists. You want to heal without the risks, downtime, and potential complications of an invasive procedure.
Desire for Faster Recovery: Whether you’re a competitive athlete or someone who wants to get back to playing with your grandchildren, you want to get better as quickly as possible.
Focus on Long-Term Tissue Health: This is perhaps the most crucial point. I can inject something to numb the pain temporarily, but are we actually helping the tissue heal? Or are we potentially causing harm down the line? My goal is not to provide a temporary fix that requires you to come back every few months for the rest of your life. Instead, we want to restore and strengthen damaged tissue and return you to your life with confidence and strength. This philosophy is at the core of regenerative and functional medicine.

Let’s consider a common scenario. A patient comes to me with a chronic tendon injury. A neurosurgeon sent them for evaluation. The problem isn’t just about pain; it’s about compromised tissue integrity. My objective is to do more than mask the symptoms. We want to change the tissue’s biology to promote a healthier, more robust state.

Understanding the Tools: Corticosteroids, HA, and PRP

When it comes to injectable treatments for joint and tendon pain, we have several tools at our disposal. It’s essential to understand what each one does, why we might use it, and what its limitations are.

Corticosteroids: The Double-Edged Sword

Corticosteroids (like cortisone) and powerful non-steroidal anti-inflammatory drugs (NSAIDs) like Toradol are well-known for providing rapid and potent pain relief. They work by aggressively shutting down the inflammatory process.

Mechanism: Corticosteroids are powerful anti-inflammatory agents. They suppress the immune response, reducing the swelling, warmth, and pain associated with inflammation.
The Downside: While they offer quick relief, this comes at a cost. Emerging research and extensive clinical observation have raised serious concerns about their long-term effects. A significant issue is chondrotoxicity, meaning they can be toxic to cartilage cells (chondrocytes). When we repeatedly inject steroids into a joint, we may be accelerating the very cartilage breakdown we are trying to prevent. Think of it this way: inflammation is part of the body’s natural healing signal. By completely silencing it, we might also be silencing the signals that call for repair and regeneration. The result is often a cycle of temporary relief followed by a return of pain, often worse than before, leading to more injections. Many patients I see have been on this “injection treadmill” and eventually end up needing surgery anyway.

Hyaluronic Acid (HA): The Joint Lubricant

Hyaluronic Acid (HA), also known as viscosupplementation, is a different approach. HA is a natural component of the synovial fluid that lubricates our joints.

Mechanism: In arthritic joints, the concentration and quality of HA are often diminished. Injecting a gel-like HA substance helps to restore the viscosity of the joint fluid. This provides better lubrication and shock absorption, improving the overall joint environment (homeostasis). It’s important to note that HA itself is not a direct anti-inflammatory in the classical sense, unlike a steroid. Its primary role is mechanical and supportive.
Application: I often think of it like this: I can inject a steroid into an “angry,” inflamed joint to calm it down, or I can add HA gel to improve the mechanics and reduce friction. In many cases, especially in an irritated joint, I might combine a short-term anti-inflammatory with HA to get the benefits of both—calming the fire and then improving the environment. In the United States, insurance typically covers HA injections only for knee osteoarthritis, but clinically, we see benefits in other joints, such as the shoulders, hips, and ankles. Patients often acquire the syringes from specialty pharmacies for these off-label applications.

Platelet-Rich Plasma (PRP): Harnessing the Body’s Healing Power

This brings us to Platelet-Rich Plasma (PRP), a cornerstone of modern regenerative medicine.

Mechanism: PRP is a concentration of your own blood platelets, which we obtain through a simple blood draw and centrifugation process. Platelets are the body’s first responders to injury. They are packed with hundreds of growth factors and signaling proteins that orchestrate the entire healing cascade. When we inject PRP directly into an injured tendon or an arthritic joint, we deliver a powerful, concentrated dose of these natural healing signals. PRP doesn’t just mask pain; it works to:
- Modulate Inflammation: Unlike steroids, which obliterate inflammation, PRP modulates it. It helps transition the inflammatory state from a chronic, destructive process to an acute, regenerative one.
- Promote Tissue Healing: It stimulates the recruitment of stem cells to the area and encourages the formation of new blood vessels (angiogenesis) and new, healthy tissue (such as collagen in tendons or cartilage components in joints).
The Outcome: By using your body’s own biological software, PRP aims to fundamentally change the tissue environment, promoting true healing and creating a more durable, functional structure. This is how we move from managing symptoms to actually restoring tissue.

The Evidence: Comparing PRP, Steroids, and HA

The scientific community has been rigorously studying these treatments, and a clear picture is beginning to emerge.

PRP vs. Corticosteroids

A growing body of high-quality research shows that for many conditions, particularly osteoarthritis and tendinopathies, PRP is superior to corticosteroids. A systematic review and meta-analysis by Belk et al. (2021) found that, for knee osteoarthritis, patients treated with PRP experienced significantly greater improvements in pain and function than those who received corticosteroid injections, with benefits lasting much longer, often up to 12 months. Steroids, in contrast, typically provide relief for only a few weeks to a few months.

PRP vs. Hyaluronic Acid (HA)

Similarly, when PRP is compared to HA for knee osteoarthritis, the evidence favors PRP. Multiple studies, including a large-scale meta-analysis published in Arthroscopy, have demonstrated that PRP provides more significant and longer-lasting improvements in both pain scores and functional outcomes at 6 and 12 months post-injection (Laudy et al., 2015). While HA can be beneficial, PRP appears to offer a more profound and durable biological effect.

Summary of Evidence Table

Treatment	Mechanism of Action	Duration of Effect	Effect on Tissue	Best For
Corticosteroids	Potent anti-inflammatory	Short-term (1-12 weeks)	Potentially chondrotoxic (damaging to cartilage) with repeated use	Acute, severe inflammatory flare-ups when other options are not feasible
Hyaluronic Acid (HA)	Joint lubrication and shock absorption	Medium-term (up to 6 months)	Supportive, improves joint homeostasis	Mild to moderate osteoarthritis, especially when insurance covers it
Platelet-Rich Plasma (PRP)	Modulates inflammation, delivers growth factors to stimulate healing	Long-term (6-12+ months)	Regenerative, promotes healing and tissue repair	Chronic tendinopathies, mild to moderate osteoarthritis, long-term tissue health

Making the Right Choice: A Patient-Centered Approach

So, how do we decide which treatment is right for you? This is where a personalized, integrative approach becomes critical. There is no one-size-fits-all answer.

For Chronic Tendinopathy or Mild-to-Moderate Osteoarthritis: If you have a long-standing issue like tennis elbow, Achilles tendinopathy, or early-to-moderate joint arthritis without severe, acute inflammation, my first recommendation is almost always PRP. It addresses the underlying degenerative nature of the problem and offers the best chance for long-term healing and functional improvement. I try to avoid steroids in these cases to protect the long-term health of the tissue.
When Cost is a Major Factor: If PRP is not financially feasible and your insurance covers HA for knee osteoarthritis, it is a very reasonable and effective option that provides better long-term outcomes than steroids. With some insurance plans now dropping coverage for HA, the cost-benefit analysis is shifting. If you are paying out of pocket, the small additional cost of PRP may provide significantly more value, as it often requires fewer treatments over time.
For Acute, Severe Pain: There are times when a patient is in so much pain that their only goal is immediate relief. In these situations, judicious use of a corticosteroid injection can serve as a bridge. It can calm a severe inflammatory flare-up enough to allow the patient to engage in physical therapy and other restorative treatments. However, I always have a conversation with the patient: “This is a temporary solution to get you out of this crisis. Once the inflammation is under control, we need to address the underlying problem to prevent this from happening again.”

The Crucial Role of Integrative Chiropractic Care

Injectable therapies, even advanced ones like PRP, are only one piece of the puzzle. If we don’t address the underlying biomechanical issues that led to the tissue breakdown in the first place, the problem is likely to return. This is where integrative chiropractic care is essential.
As a Doctor of Chiropractic (DC) and a board-certified Family Nurse Practitioner, I see the body through a unique lens. Pain and degeneration in a joint or tendon are often symptoms of a deeper functional problem.

Restoring Biomechanics: A knee doesn’t exist in isolation. Its function is directly influenced by hip and ankle mobility, core stability, and pelvic alignment. Through chiropractic adjustments, soft tissue mobilization, and specific therapeutic exercises, we work to correct these imbalances. For example, if a patient has knee osteoarthritis, I will assess their hip mobility and foot mechanics. Often, hip stiffness or poor foot posture forces the knee to take on excessive rotational stress, accelerating wear and tear. By restoring normal movement patterns in the entire kinetic chain, we offload the damaged knee joint.
Enhancing the Effects of Regenerative Injections: Performing a PRP injection without correcting the faulty mechanics is like patching a tire without fixing the alignment that caused it to wear out unevenly. The patch won’t last. Chiropractic care creates an optimal biomechanical environment for the regenerative process to succeed. By improving joint alignment and muscle function, we ensure that the newly forming tissue is not immediately subjected to the same stresses that caused the initial injury. This synergy between advanced regenerative injections and foundational chiropractic care is the key to achieving durable, long-term success.

At my clinic, a comprehensive treatment plan for a patient with knee osteoarthritis might involve a PRP injection to stimulate cartilage repair, combined with a targeted program of chiropractic adjustments to the lumbar spine and pelvis, mobilizations for the hip and ankle, and a tailored exercise regimen to strengthen the gluteal muscles and improve neuromuscular control. This holistic approach ensures we are treating not just the site of pain, but the entire system.

Final Thoughts

The world of medicine is moving away from simply managing symptoms and toward restoring function and promoting true healing. When we talk about treating joint and tendon pain, we have to consider the long-term implications of our choices.

Steroids have their place for short-term crisis management, but pose a risk to long-term tissue health.
Hyaluronic Acid is a safe and effective lubricant, offering a good supportive option for osteoarthritis.
Platelet-Rich Plasma (PRP) stands out as a superior treatment for promoting true tissue healing and offering lasting functional improvement, supported by robust scientific evidence.

Ultimately, the best approach is personalized to you—your specific condition, your goals, and your body’s unique needs. By combining advanced regenerative therapies like PRP with the foundational principles of integrative chiropractic care, we can go beyond temporary fixes and help you move toward lasting health, durability, and a full return to the life you love.

References

Belk, J. W., Kraeutler, M. J., Houck, D. A., Goodrich, J. A., Dragoo, J. L., & McCarty, E. C. (2021). Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. The American Journal of Sports Medicine, 49(9), 2498–2510. https://doi.org/10.1177/0363546520909397
Laudy, A. B. M., Bakker, E. W. P., Rekers, M., & Moen, M. H. (2015). Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. British Journal of Sports Medicine, 49(10), 657–665. https://doi.org/10.1136/bjsports-2014-094036

SEO Tags: Joint Pain, Osteoarthritis Treatment, PRP Therapy, Platelet-Rich Plasma, Hyaluronic Acid, Cortisone Injections, Regenerative Medicine, Integrative Chiropractic Care, Sports Medicine, Tendinopathy, Knee Pain, Non-Surgical Treatment, Dr. Alexander Jimenez, El Paso, TX, Functional Medicine

May 19, 2026

FDA Clarifications for PRP and Chiropractic Practice

Abstract

In this educational post, I share clear, first-person guidance on platelet-rich plasma (PRP) therapy—what it is, how the FDA views it, and how to talk about it with patients who ask about approval, safety, and consent. I explain why PRP devices can be FDA-cleared while the PRP itself is not FDA-approved, and why that distinction matters clinically and ethically. I also walk through practical ways to optimize PRP quality, including evidence-informed recommendations on exercise, diet, and NSAID use, and I discuss what we do and do not yet know from current research. Finally, I outline how integrative chiropractic care fits into PRP treatment, detailing biomechanics, neuromuscular coordination, fascial dynamics, and nociceptive modulation, and I provide stepwise protocols that I use in practice. My goal is to give clinicians and patients a structured, research-grounded path from confusion to confidence.

Introduction: Why Patients Ask About PRP Approval and Why Clinicians Need Clarity

When patients ask me whether PRP is “FDA approved,” they are really asking, “Is this safe?” Is it legitimate?” Does it work? As a clinician working across musculoskeletal medicine and integrative chiropractic care, I’ve learned that the best results come from blending transparent communication with rigorously applied, evidence-based protocols. I want to clarify the regulatory language and connect it to what we can do today to improve clinic outcomes.

I’ll start by clarifying the difference between FDA device clearance and drug approval. Then I’ll outline practical steps to enhance PRP quality, including timing of NSAIDs, diet strategies, and targeted high-intensity exercise. I’ll also share how integrative chiropractic care and functional rehabilitation synergize with PRP, based on physiological mechanisms and clinical observations I’ve discussed widely in my practice and professional communications.

FDA Status of PRP: What “Cleared” Means and Why PRP Itself Is Not Approved

Here’s the core regulatory truth: PRP kits and centrifuges—medical devices used to prepare platelet-rich plasma—can be and often are FDA 510(k)-cleared. This means the device is substantially equivalent to a legally marketed device and is cleared for specific indications, such as the separation of blood components. By contrast, the PRP itself—your plasma enriched with platelets—is an autologous biologic, not a manufactured drug. Under current rules, PRP is not “FDA approved” as a drug to treat a specific disease (like knee osteoarthritis), because it doesn’t fit the drug pathway that requires large-scale, expensive clinical trials and a manufacturer-controlled product.

Key points I share with patients:

Devices used to prepare PRP are often FDA 510(k)-cleared for blood processing.
PRP, as a biologic derived from the patient’s own blood, is not a drug and therefore does not undergo FDA drug approval.
The FDA does not “approve procedures.” It regulates products (drugs, devices, biologics) and claims. Procedures—like autologous PRP injection—are governed by the standard of care, state scope of practice, and ethical informed consent.
Clinically, we rely on peer-reviewed evidence demonstrating the benefits of PRP for certain musculoskeletal conditions, while being honest about variability and the need for individualized protocols.

Why this matters:

Patients sometimes assume a lack of “approval” means experimental. I clarify that “not FDA approved” for a biologic like PRP is a category distinction, not a verdict on quality or usefulness. We build confidence by presenting the data and setting expectations.

Informed Consent and Ethical Language: How I Explain PRP Status

In consent discussions, I use language that respects both science and patient autonomy:

I state that the device used is FDA-cleared for blood component preparation.
I explain that PRP injections are a procedure using the patient’s own blood, and the FDA does not approve procedures.
I review the evidence base: what conditions PRP has been shown to help, where results are mixed, and what factors influence outcomes.
I discuss risks, benefits, alternatives (including conservative care, physical therapy, and integrative chiropractic strategies), and the inherent uncertainty of biologic therapies.

Clinically, this avoids the misleading frame of “waiting for FDA approval.” An autologous PRP product is not a drug, and there is no drug-approval pathway for it. Instead, I emphasize the quality of evidence, the care team’s experience, and the patient’s goals.

Optimizing PRP Quality: Exercise, Diet, and NSAIDs

One of the most practical parts of PRP care is preparing the patient’s physiology for the blood draw and injection. Several modifiable factors can influence platelet count, platelet activation, and growth factor release.

High-Intensity Exercise Before Draw

What we know: Short-term high-intensity exercise can transiently increase platelet count and alter platelet activation dynamics, likely via catecholamines (epinephrine, norepinephrine), hemoconcentration, and shear stress–mediated endothelial interactions. Acute bouts (e.g., 10–20 minutes of cycling intervals) may nudge platelet counts and potentially the concentration yields of PRP during processing.
Mechanisms: Intense exercise drives sympathetic activation, raises circulating catecholamines, mobilizes platelets from the splenic reservoir, and increases shear stress, which can prime platelets. It also activates the AMPK and PGC-1α pathways in muscle, thereby shaping an anti-inflammatory milieu and beneficial epigenetic signatures in immune cells.
Practical protocol: I often have patients perform a 15–20-minute high-intensity interval bike session (if medically appropriate) shortly before a blood draw. We monitor vitals and avoid overexertion. For those unable to do intervals, brisk cycling or supervised calisthenics (e.g., jumping jacks, step-ups) can be used as alternatives.
Why I use it: The potential to increase platelet availability and enhance growth factor profiles is attractive, with low risk when supervised. While individual responses vary, the cost-benefit is favorable.

NSAIDs Before and After PRP

What we know: NSAIDs can inhibit cyclooxygenase (COX-1/COX-2) pathways, reducing thromboxane A2 synthesis, which is pivotal for platelet aggregation. In vitro, NSAIDs can disaggregate platelets and blunt activation-dependent granule release (alpha and dense granules), potentially diminishing the orchestrated regenerative signaling PRP relies upon.
Evidence is mixed regarding clinical impact. However, given PRP’s mechanism—relying on controlled platelet activation, fibrin scaffold formation, and paracrine signaling (PDGF, TGF-β, VEGF)—I recommend caution.
Practical protocol: I advise patients to avoid NSAIDs 10–14 days pre-procedure and for a similar window post-procedure unless medically necessary. We substitute with acetaminophen for analgesia and consider topical NSAIDs later if needed, depending on the anatomical site and vascular exposure.
Why I use it: It aligns with platelet physiology and avoids dampening the critical aggregation and growth factor release that PRP is intended to elicit.

Anti-Inflammatory Diet and Hydration

What we know: Nutritional status influences systemic inflammation, endothelial function, and platelet reactivity. A diet rich in omega-3 fatty acids, polyphenols (berries, green tea), and magnesium supports a balanced inflammatory tone and vascular health. Adequate hydration improves plasma volume, facilitating venipuncture and consistent processing.
Mechanisms: Omega-3s (EPA/DHA) can integrate into platelet membranes, modulating eicosanoid profiles and dampening excessive aggregation. Polyphenols influence NF-κB signaling and antioxidant capacity. Stable insulin dynamics reduce pro-inflammatory cytokines (IL-6, TNF-α).
Practical protocol: In the week leading up to PRP, I recommend:
- Emphasize omega-3-rich foods (wild-caught fish, flax, chia) or supplementation if appropriate.
- Increase colorful vegetables and polyphenol-rich fruits.
- Maintain adequate hydration; limit alcohol.
- Avoid ultra-processed foods and excessive sugar to minimize postprandial inflammation.
Why I use it: It’s low-risk, supports vascular and immune function, and aligns with regenerative goals.

Blood Flow Restriction (BFR) and Pre-Draw Conditioning

What we know: Emerging data on blood flow restriction training suggest anabolic signaling via mTOR, local hypoxia-inducible factors (HIF-1α), and increased growth hormone responses. Direct evidence on improving PRP yields is limited and mixed. Some centers incorporate brief cycling or calisthenics. A few studies suggest that BFR may modulate local platelet dynamics, but consistency has not been established.
Practical stance: I consider BFR as an adjunct for rehabilitation phases post-PRP rather than a pre-draw tool. If used pre-draw, it should be clinician-supervised and patient-specific.
Why I use it selectively: The uncertainty on PRP yield benefits doesn’t outweigh the clear rehab benefits of BFR for strength gains at low loads, which is valuable after injection.

What Counts Most: Dose, Product, and Indication

In my experience, the “core principles” are:

Using the right PRP preparation (leukocyte-poor vs. leukocyte-rich) matched to the condition.
Achieving the proper platelet concentration (often 3–7x baseline) without reaching the inhibitory threshold, where excessive concentration can paradoxically reduce efficacy.
Matching the indication: Tendinopathies and certain joint conditions respond differently. Accurate diagnosis, imaging guidance, and tissue targeting matter more than marginal gains from pre-draw hacks.

Physiological Underpinnings: Why PRP Works and Where It Struggles

PRP’s promise rests on the biological choreography of platelet activation and paracrine signaling:

Upon activation, platelets release PDGF, TGF-β, VEGF, IGF-1, and FGF, orchestrating chemotaxis, angiogenesis, fibroblast proliferation, and extracellular matrix remodeling.
The fibrin scaffold forms a localized matrix for cell migration and sustained growth factor presentation.
Leukocyte content modulates cytokine milieu. In tendinopathy, excess leukocytes may increase catabolic cytokines; in some wounds, leukocytes assist antimicrobial defense and clean-up. This is why product phenotyping matters.

Where PRP struggles:

In advanced osteoarthritis with severe cartilage loss and bone marrow lesions, PRP’s signals may be insufficient without concurrent biomechanical unloading and metabolic support.
Poor systemic health—uncontrolled diabetes, high systemic inflammation, or active smoking—can blunt regenerative signaling.

Integrative Chiropractic Care: Synergy With PRP for Musculoskeletal Healing

This is where integrative chiropractic care plays a crucial role. PRP sets the biochemical stage; chiropractic and functional rehabilitation shape the mechanical and neuromuscular context in which tissues attempt to heal.

Key domains I harmonize:

Biomechanical Alignment and Load Distribution
- Why it matters: Joint mechanics determine stress concentration zones. Malalignment increases shear forces, aggravates tendons and articular cartilage, and perpetuates nociceptive signaling.
- Protocols: After PRP injections, I use gentle segmental mobilization and targeted soft-tissue release to normalize joint play and reduce fascial adhesions. As pain reduces, we transition to closed-chain stability exercises to retrain load-bearing patterns.
- Physiological rationale: By reducing aberrant shear and restoring arthrokinematics, we lower catabolic signals (MMPs) and allow PRP-mediated anabolism to proceed.
Fascial Dynamics and Neuromuscular Coordination
- Why it matters: The fascia is richly innervated and responsive to tension. Dysregulated fascial tone contributes to pain and dysfunctional movement patterns. PRP benefits when we reduce myofascial guarding and improve proprioception.
- Protocols: I apply instrument-assisted myofascial release, PNF stretching, and breath-coordinated mobilizations. We integrate sensorimotor retraining (balance work, reactive drills) to refine neuromuscular timing.
- Physiological rationale: Improved afferent input from fascia and joint receptors recalibrates motor outputs via the spinal cord and cerebellum, reducing overuse of compensatory muscles. Better coordination reduces re-injury and supports collagen remodeling directed by PRP signals.
Nociceptive Modulation and Central Sensitization
- Why it matters: Persistent pain can upregulate central sensitization, magnifying nociception. PRP’s local effects need systemic support to downshift neural gain.
- Protocols: Gentle manual therapy, graded exposure, and breathing techniques (slow diaphragmatic breathing to enhance vagal tone) help reduce sympathetic overdrive. Sleep optimization and stress modulation are included.
- Physiological rationale: Enhancing parasympathetic activity reduces inflammatory cytokine release via the cholinergic anti-inflammatory pathway, improving recovery conditions.
Strength and Conditioning With Joint Protection
- Why it matters: Improved tissue quality is wasted without robust, well-coordinated musculature. Strength protects joints by distributing loads and stabilizing movement.
- Protocols: We progress from isometrics to eccentrics, then to controlled concentrics. For tendinopathy, eccentric loading programs remain foundational. If appropriate, BFR training enables hypertrophy at low loads during early phases.
- Physiological rationale: Mechanical loading stimulates tenocyte and chondrocyte anabolic activity via integrin signaling and mechanotransduction pathways (FAK, MAPK), synergizing with PRP’s growth factor environment.

Stepwise Integrated Protocol: From Consultation to Recovery

I use a structured approach that patients appreciate because it turns complexity into clarity:

Step 1: Medical and Functional Assessment
- Comprehensive history, medications, NSAID review, and comorbidities.
- Functional movement screening and targeted imaging, if needed.
- Discussion of goals and setting realistic expectations.
Step 2: Pre-PRP Preparation
- NSAIDs: Hold for 10–14 days pre-procedure if possible.
- Nutrition: Emphasize omega-3s, polyphenols, and hydration.
- Exercise: 15–20 minutes high-intensity intervals prior to blood draw (if safe).
- Sleep and stress: Reinforce sleep hygiene to optimize hormonal and immune balance.
Step 3: PRP Collection and Processing
- Use an FDA 510(k)-cleared device appropriate for the indication.
- Decide on leukocyte-poor vs. leukocyte-rich PRP based on target tissue and current evidence.
- Ultrasound guidance for precise placement when indicated.
Step 4: Immediate Post-Injection Care
- Avoid NSAIDs for another 10–14 days; use acetaminophen judiciously.
- Gentle mobility, protection of the injected area, and no aggressive stretching in the acute phase.
- Education on expected soreness and timelines.
Step 5: Integrative Chiropractic and Rehab Progression
- Week 1–2: Pain-modulated manual therapy, gentle mobilization, and isometrics.
- Week 3–6: Progressive eccentrics and proprioceptive training; address gait, posture, and ergonomic loads.
- Week 6+: Strength, power (if appropriate), and return-to-sport mechanics.
- Consider BFR selectively for low-load hypertrophy.
Step 6: Monitoring and Outcomes
- Reassess pain, function, and movement patterns at set intervals.
- Adjust programming based on tissue response and patient goals.
- Consider repeat PRP only when clinically justified and after biomechanical deficits are addressed.

Clinical Observations From My Practice

Across my work in El Paso and in conversations shared through my clinic’s educational platforms, I consistently observe:

Patients who follow NSAID guidance, nutrition support, and pre-draw exercise tend to have more predictable recoveries.
Matching the PRP product phenotype to the indication greatly influences outcomes. For example, leukocyte-poor PRP is often suitable for intra-articular injections, while some tendon cases benefit from a carefully titrated leukocyte content.
Integrative chiropractic interventions lower re-injury rates by correcting movement faults and fascial restrictions that would otherwise undermine PRP’s benefits.
Stress, sleep deprivation, and deconditioning are silent saboteurs. Coaching patients on these areas is as important as the injection itself.

What We Still Don’t Know—And How We Manage Uncertainty

The field continues to evolve:

The precise weighting of factors such as NSAID timing, specific exercise protocols, and BFR effects on PRP yield remains under investigation.
Ideal dosing regimens (single vs. series of injections), optimal intervals, and cross-comparisons with other orthobiologics (BMAC, microfragmented adipose tissue) are active areas of research.
Insurance coverage remains inconsistent, and large-scale trials are costly, which slows standardization.

How I navigate this:

I rely on longitudinal patient tracking, functional metrics, and imaging when needed.
I apply the precautionary principle where physiology suggests potential interference (e.g., NSAIDs).
I tailor protocols to patient-specific biomechanics and goals, integrating chiropractic care to create a favorable mechanical environment for biologic healing.

Communicating With Patients: Clear, Confident, and Compassionate

When patients ask, “Is PRP FDA approved?” I answer:

The device we use to prepare your PRP is FDA-cleared for that purpose.
Your PRP is your blood product; it is not a drug, and the FDA does not approve procedures.
We base our recommendation on studies showing benefits for your condition, our clinical experience, and a protocol designed to maximize your body’s healing response.

When they ask: “Is this experimental?”

I explain that while PRP is not “approved” like a drug, it is widely used, supported by modern studies for specific indications, and integrated into an evidence-informed care plan. We will review risks, benefits, and alternatives so you can make an informed decision.

Conclusion: A Practical, Ethical Path Forward for PRP

PRP is a powerful tool when used thoughtfully. By clarifying the distinction between FDA clearance and approval, optimizing platelet physiology through exercise, diet, and NSAID management, and embedding PRP within a comprehensive integrative chiropractic plan, we provide patients the best chance for meaningful recovery. While some variables remain under study, our responsibility is to apply the strongest available evidence, monitor outcomes, and continually refine care.

I invite patients and clinicians to adopt this structured approach and engage with our team as we continue to advance protocols grounded in science and compassionate care.

References

U.S. Food and Drug Administration: 510(k) Premarket Notification (FDA, n.d.).
American Academy of Orthopaedic Surgeons: Platelet-Rich Plasma (PRP) (AAOS, n.d.).
Everts, P. A., et al. Platelet-rich plasma and platelet lysate: review of their mechanisms of action in tissue repair and regeneration (Everts et al., 2017).
Chaudhury, S., et al. Autologous blood injections and platelet-rich plasma for tendinopathy (Chaudhury et al., 2011).
O’Connell, B., et al. The role of exercise on platelet function and hemostasis (O’Connell et al., 2015).
Hawkins, D., et al. Nonsteroidal anti-inflammatory drugs and platelet function (Hawkins et al., 2004).
Pearson, T., et al. Omega-3 fatty acids and platelet aggregation (Pearson et al., 2005).
Scott, A., et al. Eccentric training for tendinopathy: mechanotransduction pathways (Scott et al., 2009).
Hughes, L., et al. Blood flow restriction training: mechanisms and applications (Hughes et al., 2017).

May 12, 2026

Integrative Care for Plantar Fasciitis With SoftWave

Abstract

In this educational post, I share my personal journey with severe plantar fasciitis and how SoftWave shockwave therapy transformed my recovery without injections or surgery. From there, we look at modern, evidence-based research on shockwave physics and mechanisms, compare true shockwave and radial pressure-wave devices, and explore patient outcome data from independent registries. I then outline how integrative chiropractic care fits into this model, including spinal and regional joint mechanics, fascial and neuromuscular coordination, anti-inflammatory nutrition, and return-to-sport protocols. You will learn why electrohydraulic shockwave is considered a gold standard, how it triggers angiogenesis and modulates inflammation, and how to implement it alongside biologics such as PRP in a clinically rational way. Throughout, I incorporate clinical observations from my practice to demonstrate real-world application and patient-centered workflows.

Why This Matters

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. My clinical focus integrates chiropractic medicine, advanced practice nursing, functional medicine, sports science, and tissue rehabilitation. My mission is simple: deliver safe, effective, and science-driven care that helps patients return to life and sport with better long-term outcomes.

For many of my patients, chronic musculoskeletal pain feels like a maze of temporary relief and recurrent setbacks. New technologies can promise a lot but deliver unevenly. My goal in this post is to clarify the science, present real data, and show how integrative chiropractic care and SoftWave shockwave therapy can be combined to create a precise, reproducible plan of action.

From Pain To Practical Solutions: A Patient’s Plantar Fasciitis Story

Seven years ago, while working long hours on their feet as a wedding planner, a patient developed bilateral plantar fasciitis—a stubborn, burning heel pain worsened by standing, walking, and push-off mechanics. The standard recommendation the patient received was cortisone injections, which can blunt pain but may impair soft tissue healing and carry a risk of plantar fascia rupture with repeated use. The patient declined and assumed they would have to live with the pain.

A colleague introduced the patient to SoftWave shockwave therapy. Their first session was intense—older protocols often sought to “treat into pain”—but they felt relief the same day. The pain recurred within a few days, and the patient moved on. Then, two months later, the patient woke up and realized they hadn’t felt heel pain for days. They hadn’t stretched, changed footwear, or altered workload. The pain was just… gone. They stayed pain-free for nearly four years before needing another series. That experience ignited a commitment to evidence-based regenerative technologies that work with the body’s repair systems rather than against them.

What Is A Shockwave? The Physics That Matter

When you hear “shockwave,” think of a high-speed acoustic energy wave traveling faster than the speed of sound through tissue. In medicine, the waveform and speed are crucial:

True shockwave: A high-velocity acoustic wave that reaches supersonic speeds and produces a sharp pressure gradient at the leading edge. Electrohydraulic systems generate this wave inside the applicator and deliver it as a coherent, high-energy impulse.
Radial pressure wave: A lower-velocity pressure wave that disperses energy superficially and primarily creates mechanical perturbations near the skin surface.

Key physiological effects of true shockwave:

Cell membrane mechanotransduction: The rapid pressure shift causes a transient change in cell membrane permeability, initiating signaling cascades.
Angiogenesis: Upregulation of pro-angiogenic factors (e.g., VEGF) stimulates the formation of both small and large vessels, improving perfusion to hypoxic or degenerated tissues.
Inflammation modulation: Downregulation of NF-κB pathways and altered cytokine profiles can help shift chronic inflammatory states toward resolution.
Tissue remodeling: Stimulation of tenocytes, fibroblasts, and osteoblasts enhances matrix turnover, collagen alignment, and bone healing.
Analgesic neuromodulation: Changes in peripheral nociceptor sensitivity and local neuropeptide signaling can reduce pain over time without neurodestructive effects.

Why speed and waveform matter:

The steep pressure gradient of a true shockwave produces a shearing force at the cell membrane, which initiates the biological cascade (mechanotransduction).
Devices that produce sound waves that converge into a shockwave only outside the applicator may have a shorter effective burst and require precise targeting to avoid under- or overdosing tissue.
Electrohydraulic devices generate a shockwave within the applicator, providing a consistent, therapeutic energy profile that can reach deeper targets (often cited as up to approximately 12 cm, depending on tissue, coupling, and parameters).

Electrohydraulic Versus Electromagnetic/Piezoelectric: Practical Differences

There are several ways to generate shockwaves:

Electrohydraulic: Two electrodes create a spark in water, producing a cavitation bubble; the leading edge of the bubble is the shockwave. This is often considered a gold standard by clinical shockwave societies due to stable energy delivery and deeper penetration.
Electromagnetic: A magnetic coil accelerates a membrane or projectile; a shockwave forms as sound waves converge.
Piezoelectric: Arrays of crystals emit waves that focus and converge to create a shockwave in a focal zone.

Clinical implications:

Electrohydraulic systems typically deliver a full-energy shockwave at the applicator exit, reducing the “gap” between the device and the therapeutic zone.
Convergent systems (electromagnetic, piezoelectric) can be effective but may have narrow focal zones, shorter burst durations, and require meticulous targeting and tip selection.
The patient experience can differ: a broader energy distribution tends to be more comfortable, enabling higher-dose delivery without anesthesia.

True Shockwave Versus Radial Pressure Waves: Mechanisms And Outcomes

It is common to see radial devices marketed under “shockwave” branding. Mechanistically, radial devices:

Produce pressure waves at sub-shock speeds.
Disperse energy superficially, relying on microtrauma to induce reactive hyperemia and local neurogenic effects.
Can be uncomfortable, and their therapeutic depth is generally limited.

Where radial can be useful:

Short-term pain relief in superficial soft tissue conditions.
Adjunct to manual therapy for myofascial trigger points.
Situations requiring cost-effective, quick, superficial treatment.

Limitations:

The durability of results may degrade over months in chronic degenerative conditions, as suggested by independent patient-reported outcome data comparing radial and true shockwave approaches.

The Two-Wave Advantage: Focused And Broad Focus Delivery

With electrohydraulic systems, particularly those using parabolic reflectors, two effects can be achieved:

Primary focused wave: Laser-pointer-like focal energy reaching deeper tissue targets.
Broad focus column: Recovered energy from the expanding cavitation bubble is redistributed, creating a larger therapeutic zone.

Why this matters:

A larger treatment volume can address complex pain generators that are regionally interdependent (e.g., plantar fascia, intrinsic foot muscles, tibialis posterior, and soleus).
Faster treatment times due to broader coverage.
Reduced technician dependency because biofeedback cues and broader zones make precision less brittle.
Improved comfort, allowing higher energy without anesthesia.

Biofeedback: The Patient Guides The Map

One practical advantage of shockwave therapy is patient biofeedback during treatment:

Healthy tissue feels like gentle tapping.
Inflamed or damaged tissue feels sharply distinct, allowing clinicians to map hotspots and functional pain generators.
This reduces guesswork and allows real-time tailoring of energy density, pulse number, and coverage.

Sports Medicine Use Case: Rapid Return-To-Play

Consider an athlete with an adductor strain. Typical recovery for moderate strains is often 6–10 weeks, depending on grade and reinjury risk. Athletes treated with true shockwave combined with integrative rehab can sometimes return in 3–4 weeks when:

Deep perfusion is improved via angiogenesis and vasodilation.
Pain is modulated without masking protective reflexes.
Tissue remodeling is supported with eccentric loading, neuromuscular re-education, and fascia mobility during the subacute window.

Orthopedic Insights From Elite Sports

Orthopedic specialists serving NBA and NFL athletes frequently use shockwave for:

Bone edema
Slow-healing fractures
Post-operative nonunion risk
Soft tissue tendinopathies

These clinicians report greater patient tolerance with true shockwave devices that deliver comfortably, thereby allowing higher-energy dosing without anesthesia and consistent day-to-day clinic throughput. This aligns with the published literature demonstrating the utility of shockwaves in bone and tendon biology through angiogenesis and mechanotransductive signaling.

How Integrative Chiropractic Care Fits The Model

Shockwave therapy works best in an integrative framework that addresses mechanical, neurophysiological, metabolic, and behavioral dimensions. In my clinic, we approach musculoskeletal problems through the following pillars:

Biomechanics and joint mechanics:
- Correct regional alignment: In plantar fasciitis, foot pronation, tibial internal rotation, and hip mechanics create downstream overload on the plantar fascia. Chiropractic adjustments to the subtalar joint, midfoot, and pelvis can redistribute load and normalize gait.
- Improve segmental mobility: Thoracolumbar stiffness can degrade shock absorption; lumbar-pelvic adjustments support kinetic chain efficiency.
Fascial continuity and neuromuscular coordination:
- Fascia connects the foot to the calf, hamstrings, and the lower back via myofascial chains. SoftWave improves perfusion and tissue pliability, while chiropractic soft-tissue work promotes gliding and hydration of the fascial planes.
- Focused motor control drills retrain the intrinsic foot muscles, the tibialis posterior, and the hip abductors to prevent recurrence.
Load management and graded exposure:
- Implement eccentric loading and isometric pain-modulating holds to enhance collagen remodeling in tendons under safe strain.
- Use return-to-sport progressions based on pain response, strength benchmarks, and functional testing (e.g., single-leg hop, Y-balance).
Anti-inflammatory nutrition and recovery biology:
- Encourage omega-3 fatty acids, polyphenols (curcumin, quercetin), vitamin D, magnesium, and targeted collagen peptides to support connective tissue health.
- Address sleep architecture and stress modulation, which influence cytokine profiles and healing velocity.
Footwear, orthotics, and surface management:
- Consider temporary orthotic support to unload the plantar fascia during high-volume training weeks.
- Optimize shoe geometry (heel-to-toe drop, midfoot stiffness) to improve force distribution.

Clinical Observations From My Practice

Across multiple musculoskeletal conditions, I observe:

Immediate reductions in pain scores following shockwave, especially when combined with regional adjustments and fascial mobilization.
Durability improves when patients receive structured motor retraining and metabolic support.
In tendinopathies (patellar, Achilles, gluteal), pairing shockwave therapy with progressive eccentric loading and coaching on stride or jump mechanics yields superior outcomes compared with passive care alone.
For bone edema and stress reactions, true shockwave paired with relative rest, calcium/vitamin D, and careful return-to-impact criteria often accelerates readiness while reducing reinjury risk.

True Shockwave And Biologics: Rational Combinations

Shockwave interacts with biologic therapies thoughtfully:

Same-day approach:
- Use shockwave to reduce pain and increase perfusion; perform PRP or cellular biologic injection afterward. Patients often tolerate injections better due to the immediate analgesic effects.
Pre-injection priming:
- Deliver shockwave 2–3 days prior to biologic injection to enhance vascularity and cellular signaling, potentially improving biologic distribution and response.
Diagnostic reinforcement:
- Use shockwave biofeedback to identify pain generators with a witness present; document patient responses to localize pathology and justify targeted biologic therapy.

Why each protocol makes sense:

Shockwave-induced vasodilation and angiogenic signaling can facilitate biologic dispersion and nutrient delivery.
Modulation of inflammation reduces hostile cytokine environments that can degrade biologic efficacy.
Analgesia without anesthesia preserves protective neuromuscular control, reducing the risk of overloading post-injection immediately.

Device Selection And Practical Considerations

If you are evaluating devices:

Prioritize true shockwave generation with consistent energy delivery and sufficient depth.
Evaluate energy distribution patterns: A broad focus column plus focus offers versatility for both diffuse and focal pathologies.
Consider patient comfort: Devices that deliver higher energy comfortably improve compliance and throughput.
Assess training and workflow: Systems that are biofeedback-guided and easy to delegate to trained staff can streamline care without compromising safety.

Clinic Workflow And Patient Experience

Shockwave sessions in my clinic typically last 10–15 minutes. We:

Conduct a focused functional exam and pain provocation tests.
Use biofeedback mapping to guide energy dosing.
Immediately follow with manual therapy, chiropractic adjustments, and targeted exercises to lock in gains.
Provide home care protocols: gentle mobility, isometric holds, footwear guidance, and nutrition.
Track outcomes using PROMs (pain scales, LEFS, VISA-A for Achilles, etc.) to quantify progress and justify care plans.

Cost And Access

Shockwave therapy is often a cash-based service, though some regions and payers may offer limited reimbursement for specific indications. In my experience, patients value:

Rapid relief
Non-invasive approach
Fewer injections
Evidence-backed tools

Transparent pricing, clear expectations, and outcome tracking build trust and encourage adherence.

Use Cases: Plantar Fasciitis, Tendinopathy, And Bone Edema

Plantar fasciitis:
- Address degenerative microtears and fibrosis with shockwave-induced angiogenesis and matrix remodeling.
- Integrate foot mechanics correction, calf flexibility, and eccentric loading.
- Typical plan: 3–6 sessions over 4–8 weeks, tailored by pain and function.
Achilles and patellar tendinopathy:
- Target mid-substance degeneration and enthesis changes using focused energy.
- Pair with tempo-controlled eccentrics and isometric protocols (45–60 second holds for pain modulation).
Bone edema and slow-healing fractures:
- Use shockwave to stimulate osteogenesis and microcirculation, while managing load and nutrition.
- Coordinate with imaging and orthopedic oversight for safe progression.

Physiological Underpinnings: Why These Techniques Work

Mechanotransduction: Shockwave applies mechanical stress that cells convert into biochemical signals—a core regenerative cue in tendon and bone.
Angiogenesis and perfusion: Chronic pain is often a story of oxygen debt. Improving microvascular flow restores the redox balance, supports ATP production, and accelerates matrix repair.
Inflammation resolution: Many chronic conditions are stuck in an immune loop of low-grade inflammation. Shockwave can shift cytokine profiles toward resolution, enabling fibroblasts and tenocytes to remodel effectively.
Neuromodulation: Pain reduction without nerve ablation allows normal motor learning and movement quality to return during rehab—a safer, smarter approach.

Implementation Roadmap For Clinicians

Assess:
- Identify pain generators via functional testing and biofeedback mapping.
- Consider imaging for bone edema or complex tendinopathy.
Plan:
- Select energy levels and pulse counts based on tissue depth and patient tolerance.
- Integrate chiropractic adjustments, manual therapy, and exercise on the day of.
Deliver:
- Keep sessions short, progressive, and guided by patient feedback.
- Use a broad focus for regional complaints and focused energy for pinpoint lesions.
Reinforce:
- Provide home protocols, nutrition plans, and sleep hygiene.
- Schedule follow-ups and measure outcomes with standardized scales.
Combine when indicated:
- Coordinate with PRP or other biologics using same-day or pre-injection priming.
- Document responses to build a data-informed case, improving patient consent and expectations.

What Patients Feel And How We Adjust

Early sessions may include transient soreness at hot spots; this is expected and short-lived.
Most patients feel immediate lightness or reduced pain, making subsequent rehab easier.
If discomfort increases, we adjust energy or coverage while maintaining therapeutic intent.

Safety And Contraindications

Avoid direct application over malignancy, active infection, or open wounds.
Caution with pregnancy over the abdomen/low back.
Coordinate with cardiology for anticoagulated patients near deep vascular structures.
For acute complete tendon ruptures, shockwave is not a substitute for surgical repair; we use it post-operatively when cleared.

A Real-World Example: Return-To-Sport Strategy

For a competitive court-sport athlete with adductor strain:

Week 0–1:
- Shockwave to the adductor complex and pelvic attachments.
- Chiropractic adjustments for pubic symphysis and sacroiliac joints.
- Isometric adductor holds, gentle mobility, and anti-inflammatory nutrition.
Week 2–3:
- Progressive eccentric adductor loading and lateral movement drills.
- Continue shockwave as symptoms guide; expand coverage to hip flexors and gluteal stabilizers.
- Gait and stride mechanics corrections.
Week 3–4:
- Introduce change-of-direction, acceleration/deceleration, and reactive drills.
- Clearance based on pain-free function, strength symmetry, and field tests.

In practice, this integrative plan frequently compresses recovery timelines while preserving tissue integrity.

Where To Learn More

For clinicians and patients interested in exploring shockwave research, professional societies and independent registries offer robust resources. You will find clinical guidelines, mechanisms, and outcome data across tendon, bone, and soft tissue conditions.

Training, Support, And Workflow Integration

Clinics that implement shockwave successfully typically:

Receive hands-on training from experienced providers.
Adopt biofeedback mapping in daily workflow.
Leverage marketing assets to educate their community and referrers.
Track PROMs and share outcomes in peer forums to refine protocols.

Closing Thoughts: Bringing Science, Skill, And Compassion Together

Patients with chronic pain taught me a simple truth: the body is eager to heal when given the right signals. SoftWave shockwave therapy delivers those signals powerfully and safely. When combined with integrative chiropractic care, targeted exercise, and smart biologics, the results are often transformative. Patients do not need to rely solely on injections or tolerate long downtimes. They need a coherent, evidence-informed plan that respects physiology, mechanics, and lived experience.

If you are struggling with chronic pain or you are a clinician looking for a better way, consider a thoughtful shockwave-based approach integrated with chiropractic biomechanics, fascia care, and functional medicine. It is not just about feeling better today—it is about building durable health for tomorrow.

References

International Society for Medical Shockwave Treatment (ISMST): Clinical guidelines and resources (n.d.). Clinical guidance on shockwave mechanisms, indications, and safety.
SoftWave Therapy: Research library and compendium (n.d.). Device-specific studies, international compendium, and clinical applications.
ChiroMed: Clinical observations and integrative care insights by Dr. Alexander Jimenez (n.d.). Practice-based evidence and case-informed protocols.
Dr. Alexander Jimenez, LinkedIn professional profile: Sports medicine and functional chiropractic integration (n.d.). Professional background and clinical updates.

May 11, 2026

Ultrasound Therapy Benefits and Uses For The Musculoskeletal System

Find out how ultrasound therapy provides effective solutions for chronic musculoskeletal pain and joint issues.

Abstract

As a clinician with a diverse background in chiropractic, nursing, and functional medicine, I have dedicated my career to integrating the most advanced, evidence-based tools into patient care. This post explores the transformative role of musculoskeletal ultrasound (MSKUS), a powerful, real-time imaging modality that has revolutionized the way we diagnose and treat soft-tissue injuries. We will embark on a journey through the sonographic appearance of various tissues—tendons, muscles, cartilage, ligaments, and nerves—understanding their unique visual signatures. I will share insights from leading researchers and practical clinical pearls from my own practice on interpreting these images, including the critical concept of anisotropy. Furthermore, we will delve into proper probe handling techniques for both diagnostic and procedural applications, emphasizing methods that set clinicians up for success. Finally, I will explain how these advanced diagnostic capabilities integrate with a holistic, integrative chiropractic approach, enabling more precise, effective, and patient-centered treatment plans that support true healing.

Understanding the Language of Ultrasound: Echogenicity Explained

In my practice, I often refer to musculoskeletal ultrasound as a “glorified flashlight” that allows us to peer directly into the body’s anatomy in real time. But to understand what we’re seeing, we must first learn its language. The fundamental concept is echogenicity, which describes how tissues reflect ultrasound waves.

Hyperechoic: Tissues that appear bright white on the screen. These structures, like bone, are dense and reflect most ultrasound waves to the probe.
Hypochoic: Tissues that appear dark gray. These structures, like muscle or fluid, absorb more ultrasound waves and reflect fewer.
Anechoic: Tissues that appear completely black. These are typically fluid-filled structures, such as cysts or bursae, that transmit almost all sound waves.
Isoechoic: Tissues that have a similar brightness or echotexture to adjacent structures.

Pattern recognition is the cornerstone of interpreting ultrasound images. Each tissue type has an expected appearance, and deviations from this norm can signal pathology.

Sonographic Signatures of Key Musculoskeletal Tissues

Let’s explore what healthy tissues look like under the lens of an ultrasound probe.

Tendons: The Body’s Strong Cords

Tendons are the strong, fibrous cords that connect muscle to bone. On ultrasound, a healthy tendon has a classic appearance: it’s hyperechoic (bright) and displays a distinct fibrillar pattern—think of it as a tightly packed bundle of cables or parallel stripes.

For example, when we look at the patellar tendon in a long-axis view (aligned with the tendon), we expect to see a bright, organized, striped pattern. Beneath it, we can identify other structures, such as the infrapatellar fat pad (which has a more wavy, less organized appearance) and the hyperechoic surfaces of the patella and tibia. Recognizing this norma, fibrillar architecture is crucial because when a tendon is injured (tendinosis or a tear), it loses this organization, thickens, and appears more hypoechoic (darker).

Muscles: The Engines of Movement

Muscle tissue presents a more complex, mixed-echogenicity pattern. It is generally hypoechoic compared to the bright white of bone. However, within the muscle belly, you’ll see hyperechoic strands of connective tissue, known as the perimysium, which encase the muscle fascicles. This gives healthy muscle a “marbled” or “feathery” appearance.

When viewing a muscle like the bicep or deltoid over the humerus, you can see the dark muscle tissue contrasted against the bright cortical line of the bone. You can even appreciate its structure, tapering towards its tendinous insertion. This visual information helps us identify muscle strains, tears, or atrophy.

Cartilage: Smooth Surfaces and Tough Cushions

Cartilage is a critical tissue, and ultrasound helps us differentiate between its two main types:

Hyaline Cartilage: This is the smooth, glassy cartilage that covers the ends of bones within a joint, allowing for low-friction movement. On ultrasound, it appears as a distinct, thin, hypoechoic (dark) line sitting directly on the bright, hyperechoic bone surface. A great example is viewing the posterior aspect of the humeral head in the shoulder joint.
Fibrocartilage: This is a tougher, more fibrous type of cartilage found in structures like the meniscus of the knee or the labrum of the shoulder and hip. Unlike hyaline cartilage, fibrocartilage is hyperechoic (brighter) and has a more triangular or wedge-shaped appearance. On the shoulder, you can clearly distinguish the bright, triangular labrum from the dark, linear hyaline cartilage on the humeral head.

Ligaments: The Stabilizers

Ligaments, which connect bone to bone, look very similar to tendons on ultrasound. They are also hyperechoic and have a fibrillar, striated pattern. The key difference is that ligaments are typically more compact and densely packed than tendons.

The true power of ultrasound in evaluating ligaments comes from its real-time, dynamic capabilities. The best way to confirm you are looking at a ligament is to trace it from one bony attachment to another. If it originates from or inserts into a muscle, it’s a tendon. With ligaments such as the Medial Collateral Ligament (MCL) of the knee, we can perform a stress test under direct visualization. By applying a valgus force to the knee, we can watch the ligament in real time to see if there is any “gapping” or separation of its fibers.

A report might read: “The linear probe was placed over the medial aspect of the knee, and the MCL was visualized in a long-axis view. Upon real-time valgus stress, there was observable gapping of the mid-substance fibers with surrounding hypoechoic fluid, consistent with a grade 2 sprain.” This level of detail is impossible with a static MRI.

Nerves: The Body’s Electrical Wiring

Nerves have a unique and fascinating appearance on ultrasound, often described as a “honeycomb” in short-axis (cross-section) view. This pattern is created by the hypochoic nerve fascicles (the bundles of nerve fibers) surrounded by the hyperechoic epineurium (the connective tissue sheath).

In a long-axis view, the nerve can look like a bundle of parallel “railroad tracks,” though this view is often less distinct than the honeycomb cross-section. A clinical pearl I share with my students is that nerves are often easier to spot when you scan. The distinct honeycomb pattern moves through the surrounding tissue, catching your eye more readily than the linear patterns of tendons or muscles. The carpal tunnel is the classic location to visualize this, as the median nerve’s honeycomb structure stands out clearly against the adjacent flexor tendons in the forearm.

The Challenge of Anisotropy: A Critical Pitfall to Avoid

One of the most important concepts in MSKUS is anisotropy. This phenomenon occurs when the ultrasound beam is not perfectly perpendicular (at a 90-degree angle) to the structure being imaged, particularly tendons and ligaments. When the beam hits the tissue at an angle, the sound waves are reflected away from the probe instead of back to it. This lack of returning signal causes the normally bright, hyperechoic tissue to appear artifactually hypochoic, or dark.

Why is this so critical? Because a tendon tear also appears as a hypoechoic defect. Anisotropy can mimic pathology, leading to a false-positive diagnosis.

Here’s how we differentiate:

Prove the Pathology: If you see a dark spot in a tendon, like the supraspinatus tendon at its insertion on the humerus, you must prove it’s real.
Toggle the Probe: Carefully “heel-toe” or “toggle” the probe to ensure you are perfectly perpendicular to the tendon fibers at that exact spot.
Observe the Change: If the dark spot disappears and brightens when you adjust the probe angle, it indicates anisotropy. If the dark spot remains dark no matter how you angle the probe, it is more likely to be true pathology, such as tendinosis or a tear.

In my practice, I live by the mantra taught in orthopedic surgery: “One view is no view.” I always confirm a suspected finding from multiple angles, in both long and short-axis views, and correlate it with a dynamic assessment and the patient’s physical exam. This meticulous approach is what separates a novice from an expert operator and ensures diagnostic accuracy.

Mastering the Tool: Proper Probe Handling Techniques

Ultrasound is operator-dependent. Your skill in handling the probe directly impacts the quality of your images and the accuracy of your diagnosis.

The Tripod Grip for Diagnostic Scanning

For diagnostic imaging, stability and fine control are paramount. The “death grip,” where you wrap your whole hand around the probe, is unstable and limits fine motor control. Instead, we use the tripod technique.

Hold the probe like a pencil, using your thumb and index finger for control.
Brace your remaining fingers (pinky, ring, and/or middle finger) on the patient’s skin.
This creates a stable base, allowing subtle, precise movements such as sliding, toggling (heel-toe), and rotating to remain perpendicular to curved structures and eliminate anisotropy.

Your hand should be in contact with the patient. This is a more connected, controlled experience that allows you to feel the anatomy as you visualize it.

Modifying the Grip for Procedural Guidance

When performing an ultrasound-guided injection, the grip must change. Holding the probe with your fingers wrapped around it can physically block your needle’s path. For this reason, I advocate for holding the probe by its edges, which keeps your fingers clear of the sterile field and the needle’s intended path.

In-Plane Technique: For this approach, in which the needle is inserted parallel to the probe’s long axis and visualized along its entire length, a pencil-like grip is often effective.
Out-of-Plane Technique: In this approach, where the needle is inserted perpendicular to the probe and appears as a bright dot in cross-section, holding the probe by its edges provides the necessary space.

The key is to be facile, comfortable moving the probe in different ways for different tasks. Pre-planning your procedure is essential. My protocol is simple:

Find the Target: Use your scanning skills to locate the exact anatomical target.
Stay Perpendicular: Position the probe directly over the target, perpendicular to the skin. This simplifies your needle trajectory.
Bring Tip to Target: Once you have a clear, stable view of your target, you can confidently guide your needle tip precisely where it needs to go.

This methodical approach minimizes “searching” for the needle or the target, making procedures faster, safer, and more successful.

Integrative Chiropractic Care and Ultrasound Synergy

So, how does this high-tech imaging fit into a chiropractic and functional medicine framework? Perfectly.

At our clinic, we don’t just treat symptoms; we seek to understand and correct the underlying biomechanical and physiological dysfunction. MSKUS is an invaluable tool in this process.

Precision Diagnosis: Before I perform a chiropractic adjustment or recommend a course of rehabilitative exercise, I want to know exactly what tissue is injured. Is that shoulder pain from a rotator cuff tear, biceps tendinopathy, or bursitis? Ultrasound tells me instantly, allowing me to tailor my treatment. For instance, if I identify a partial tear in the supraspinatus tendon, I can modify my spinal and extremity adjustments to avoid stressing the injured tissue and instead focus on improving scapular mechanics to offload the tendon.
Guiding Soft Tissue Therapies: Many of our treatments involve soft-tissue mobilization, such as Active Release Technique (ART) or the Graston Technique. Ultrasound allows me to visualize fibrotic adhesions or scar tissue and specifically target these areas, making the treatment more efficient and effective.
Monitoring Healing: Ultrasound provides objective evidence of tissue healing. We can track the reduction of inflammation, the reorganization of collagen fibers in a healing tendon, or the decrease in fluid within a bursa over time. This helps us advance the patient’s rehabilitation protocol based on actual tissue physiology rather than just subjective pain reports.
Patient Education: Showing a patient a real-time image of their injury is incredibly powerful. When they can see the inflamed bursa or the tear in their tendon, it enhances their understanding and improves their adherence to the treatment plan. It transforms the abstract concept of their injury into something tangible.

Ultimately, musculoskeletal ultrasound elevates the practice of integrative chiropractic care. It bridges the gap between a physical exam and a definitive diagnosis, allowing a level of precision previously unattainable in clinical settings. It helps us create highly specific, evidence-based treatment plans that address the root cause of a patient’s pain and dysfunction, accelerating their path back to optimal health and function.

As of May 2nd, 2026, the technology continues to evolve, but its core value remains: it is a safe, dynamic, and profoundly insightful tool that, in the hands of a skilled operator, can truly transform patient outcomes.

References

Jacobson, J. A. (2017). Fundamentals of Musculoskeletal Ultrasound (3rd ed.). Elsevier.

McNally, E. G. (2014). Practical Musculoskeletal Ultrasound (2nd ed.). Elsevier.

The Ultrasound Site. (n.d.). Musculoskeletal Ultrasound. Retrieved from https://www.theultrasoundsite.co.uk/

Ultrasound For Movement Disorders. (n.d.). MSK Resources. Retrieved from https://www.ultrasoundformovementdisorders.com/

SEO Tags: Musculoskeletal Ultrasound, MSKUS, Integrative Chiropractic, Dr. Alexander Jimenez, Echogenicity, Anisotropy, Tendinopathy, Ligament Sprain, Nerve Entrapment, Ultrasound-Guided Injections, Functional Medicine, Chiropractic Care, Sports Medicine, Diagnostic Imaging, Soft Tissue Injury, El Paso Chiropractor, Probe Handling

Tag: Tendinopathy

PRP Injection Timing and Chiropractic Pain Relief

Abstract

Patient Candidacy for PRP: Symptoms, Not Strict Cutoffs

Setting Realistic Expectations and Timeframes

Leukocyte-Rich vs Leukocyte-Poor PRP: Mechanisms and Use-Cases

Dosing, Layering, and Volume Strategies

Steroid Washout Timing Before PRP

Post-Injection Pain, Swelling, and Frozen Shoulder Considerations

Peptides Like BPC-157: What the Evidence Says

Statins and Muscle Repair: Nuanced Considerations

Single vs Series PRP Injections: Risk, Cost, and Efficacy

Integrative Chiropractic Care: Biomechanics Meets Biology

Exosomes, Plasma Proteins, and “Top-Layer” Strategies

Case Touchpoints: Lessons from the Clinic

Why We Choose Each Technique: The Physiological Underpinnings

Stepwise Protocol I Use in Practice

What I Tell Patients

Key Takeaways

References

PRP Therapy Overview for Non-Surgical Musculoskeletal Care

Abstract

Why We Seek Alternatives to Traditional Approaches

Understanding the Tools: Corticosteroids, HA, and PRP

Corticosteroids: The Double-Edged Sword

Hyaluronic Acid (HA): The Joint Lubricant

Platelet-Rich Plasma (PRP): Harnessing the Body’s Healing Power

The Evidence: Comparing PRP, Steroids, and HA

PRP vs. Corticosteroids

PRP vs. Hyaluronic Acid (HA)

Summary of Evidence Table

Making the Right Choice: A Patient-Centered Approach

The Crucial Role of Integrative Chiropractic Care

Final Thoughts

References

FDA Clarifications for PRP and Chiropractic Practice

Abstract

Introduction: Why Patients Ask About PRP Approval and Why Clinicians Need Clarity

FDA Status of PRP: What “Cleared” Means and Why PRP Itself Is Not Approved

Informed Consent and Ethical Language: How I Explain PRP Status

Optimizing PRP Quality: Exercise, Diet, and NSAIDs

NSAIDs Before and After PRP

Anti-Inflammatory Diet and Hydration

Blood Flow Restriction (BFR) and Pre-Draw Conditioning

What Counts Most: Dose, Product, and Indication

Physiological Underpinnings: Why PRP Works and Where It Struggles

Integrative Chiropractic Care: Synergy With PRP for Musculoskeletal Healing

Stepwise Integrated Protocol: From Consultation to Recovery

Clinical Observations From My Practice

What We Still Don’t Know—And How We Manage Uncertainty

Communicating With Patients: Clear, Confident, and Compassionate

Conclusion: A Practical, Ethical Path Forward for PRP

References

Integrative Care for Plantar Fasciitis With SoftWave

Abstract

Why This Matters

From Pain To Practical Solutions: A Patient’s Plantar Fasciitis Story

What Is A Shockwave? The Physics That Matter

Key physiological effects of true shockwave:

Why speed and waveform matter:

Electrohydraulic Versus Electromagnetic/Piezoelectric: Practical Differences

True Shockwave Versus Radial Pressure Waves: Mechanisms And Outcomes

The Two-Wave Advantage: Focused And Broad Focus Delivery

Biofeedback: The Patient Guides The Map

Sports Medicine Use Case: Rapid Return-To-Play

Orthopedic Insights From Elite Sports

How Integrative Chiropractic Care Fits The Model

Clinical Observations From My Practice

True Shockwave And Biologics: Rational Combinations

Device Selection And Practical Considerations

Clinic Workflow And Patient Experience

Cost And Access

Use Cases: Plantar Fasciitis, Tendinopathy, And Bone Edema

Physiological Underpinnings: Why These Techniques Work

Implementation Roadmap For Clinicians

What Patients Feel And How We Adjust

Safety And Contraindications

A Real-World Example: Return-To-Sport Strategy

Where To Learn More

Training, Support, And Workflow Integration